title: New treatment option for adult-onset limbal xanthogranuloma.
authors.forename: Mehmet C
authors.initials: MC
authors.lastname: Mocan
authors.forename: Banu
authors.initials: B
authors.lastname: Bozkurt
authors.forename: Diclehan
authors.initials: D
authors.lastname: Orhan
authors.forename: Gamze
authors.initials: G
authors.lastname: Kuzey
authors.forename: Murat
authors.initials: M
authors.lastname: Irkec
mesh_terms: D015415:Biomarkers / Q000378:metabolism; D003316:Corneal Diseases / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D005500:Follow-Up Studies; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D015552:Injections, Intralesional; D016850:Limbus Corneae / Q000473:pathology*; D014222:Triamcinolone Acetonide / Q000627:therapeutic use*; D014972:Xanthogranuloma, Juvenile / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology
chemical_list: D015415:Biomarkers; D005938:Glucocorticoids; D014222:Triamcinolone Acetonide